Need Help?

Lipomatous tumors with 12q amplification

The project concerns whole genome sequencing (short-read and long-read) and RNA-sequencing of lipomatous tumors with 12q-amplification. A subset of lipomatous tumors is driven by amplification of genes mapping to chromosome arm 12q, including the MDM2 gene. The goals of the study were to compare expression levels of genes mapping to 12q in tumors with amplification in rod-shaped or circularized chromosomes as well as to assess and compare the structural variants in those tumors. In total, 20 samples were analyzed, and the data were correlated with genomic data on bulk and single cell DNA from the same tumors. The fastq files from the tumors were uploaded to EGA.

Request Access

Data access agreement liposarcoma

DATA ACCESS AGREEMENT between Lund University, P. O. Box 117, SE-221 00 Lund, Sweden, (hereinafter referred to as the “University”); and [name], [address], (hereinafter referred to as the “Recipient”); each a ‘Party’ and together the ‘Parties’. This agreement (the “Agreement”) is made on the last day of signature here below (the “Agreement Date”). BACKGROUND (A) The University’s Department of Laboratory Medicine, Division of Clinical Genetics is the owner of human genetic data relating to the research regarding amplification of 12q in lipomatous tumors presented in “MDM2 amplification in rod-shaped chromosomes provides clues to early stages in circularized gene amplification in liposarcoma” by Sydow et al., for which the University has received approval from the Swedish Ethical Review Authority (Dnr 2023-01550-01). (B) Pursuant to the request by the Recipient, the University has agreed to make the Data available to it for research purposes. OPERATIVE TERMS 1 Definitions and Interpretation 1.1 “User” means a researcher (or an individual conducting Research under the supervision of a researcher) who is employed by the Recipient and is bound by the terms and conditions of this Agreement. For the avoidance of doubt, “User” may also include students, visiting academics, contractors, sub-contractors or independent consultants provided that any such individual is bound by obligations no less onerous then those binding the Recipient’s employees. 1.2 ‘”Data” means the human genetic data obtained by the University. 1.3 “Data Subjects” means the individual to whom Data refers. 2 Access to Data 2.1 In consideration of the University agreeing to supply the Data to the Recipient, the Recipient agrees to be bound by the terms and conditions of this Agreement. The Recipient shall ensure that all Users are aware of and comply with the terms of the Agreement. 2.2 Recipient shall only use Data for the advancement of non-commercial biomedical research as specified in the data application form provided by the University and attached hereto as Appendix 1. 2.3 The Recipient agrees to only give access to Data, in whole or part, or any identifiable material derived from the Data, to Users. The Recipient agrees that before it gives any User access to Data, it shall first show the User a copy of this Agreement and shall inform the User that he or she must comply with the obligations contained in this Agreement and sign up to the provisions of this Agreement in the form set out at the end of this Agreement. The Recipient shall provide the University with a copy of the User’s acceptance form within thirty (30) days of the date of acceptance by the User. 2.4 The Recipient shall refer to the University all requests from third parties/persons not working under the direct supervision of the Recipient for supplies of the Data. 3 Data protection and confidentiality 3.1 Recipient agrees to comply with EU legislation on data protection when processing Data and to preserve, at all times, the confidentiality of the Data. Recipient further agrees to not attempt to identify the Data Subjects, redistribute the Data, or any subset or derivative of the Data, that could be used to identify the Data Subject, or in any other way compromise or otherwise infringe the confidentiality of information on Data Subjects and their right to privacy. 3.2 Where required under applicable laws regulating cross-border transfers of Personal Data, including European data protection laws, the parties, or their affiliates, will execute any further agreements or undertakings required to enable the lawful transfer of Personal Data, including where appropriate the EU standard contractual clauses for transfers of Personal Data to non-EU data processors set out in European Commission Decision 2010/87/EC of 5 February 2010 available at: http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:039:0005:0018:EN:PDF or such standard contractual clauses as are then in force. 3.3 The Recipient agrees that it shall take all reasonable security precautions to keep the Data confidential, such precautions to be no less onerous than those applied in respect of the Recipient’s own confidential information. 4 Errors The Recipient agrees to notify the University of any errors detected in the Data. 5 Ownership of the Data 5.1 The Data and all intellectual property in them shall at all times remain the property of the University. 5.2 The Recipient and its Users shall have the right to develop Intellectual Property based on comparisons with their own data. Recipient and User recognise that nothing in this agreement shall operate to transfer to the Recipient any intellectual property rights relating to the Data. 6 Publications and reporting The Recipient agrees to acknowledge in any work based in whole or part on the Data, the published paper from which the Data derives, the version of the Data, and the role of the University in its distribution. The Recipient will also declare in any such work that those who carried out the original analysis and collection of the Data bear no responsibility for the further analysis or interpretation of it by the Recipient. The Recipient undertakes that the Data and Confidential Information will only be used by the Recipient and Users for the sole purpose of the academic research and will not be used for any commercial purpose or commercially sponsored research. 7 Warranties 7.1 The Recipient accepts and agrees that the Data are experimental in nature and that they are supplied by the University on an ‘as is’ basis. The University makes no representation and gives no warranty or undertaking in relation to them whatsoever and excludes all implied warranties to the fullest extent permitted by law; 7.2 In particular, the University makes no representations or warranties, express or implied: • as to title, quality or fitness for a particular purpose or use of the Data; or • that the supply by the University or the use by the Recipient of the Data will not infringe the intellectual property rights of any third party. 7.3 The Recipient warrants that, in relation to the Data and their use: • they will comply with all relevant legislation and regulations; and • they have obtained all necessary consents and ethical approvals. 8 Liability 8.1 The University accepts no liability for loss of data, loss of profit, business or goodwill and all other indirect or consequential loss or damage suffered or incurred by the Recipient or by any other person arising from the supply of the Data or the use, keeping, or disposal of the Data. 8.2 The Recipient shall defend, indemnify and hold the University, its officers, employees and agents harmless against any loss, claim, damage or liability including reasonable legal costs and fees (of whatsoever kind or nature) which may arise in connection with the Recipient’s breach of this Agreement or the use, keeping, production or disposal of the Recipient or on its behalf, unless caused by the University’s gross negligence or wilful act or omission. 9 Termination 9.1 This Agreement shall take effect from the Agreement Date and will terminate on a Party giving 30 days’ prior written notice to the other; or upon breach by the Recipient or Users of any of the terms of this Agreement. 9.2 Upon termination of this Agreement or upon service of notice of termination by a Party for any reason whatsoever, the Recipient shall discontinue its use of the Data and shall, in accordance with the directions of the University, at its own cost and expense destroy the Data or return it to the University. 10 Notices 10.1 The Recipient will do all such acts and execute such documents as are required by the University to give effect to the terms of this Agreement or to enable the University to enjoy the full benefit of this Agreement (including but not limited to ownership of the Data and the arising intellectual property). 10.2 Recipient accepts that it may be necessary for the University or its appointed agent to alter the terms of this Agreement from time to time in order to address new concerns. In this event, the University or its appointed agent will contact Recipient to inform Recipient of any changes and Recipient agrees that Recipient’s continued use of the Data shall be dependent on the parties entering into a new version of the Agreement. 10.3 The Recipient may not assign or transfer all or any of its rights or obligations under this Agreement without the prior written consent of the University. 10.4 This Agreement is subject to Swedish substantive law. 10.5 Any dispute, controversy or claim arising out of or in connection with this Agreement, or the breach, termination or invalidity thereof, shall be solved by Swedish courts. This Agreement has been drawn up in two (2) original copies, each Party receiving one duly signed copy thereof. Signed …………………………….. Signed ……………………………… Authorised signature for and on behalf of Lund University Authorised signature for and on behalf of Recipient [please fill in the name of recipient] Name Name Position Position Dated Dated For the User (s):I acknowledge that I have read and understand the terms of this Agreement Signed ……………………………… Name Position Dated

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS50000000062 Cancer Genomics
  • I have added long-read whole genome sequencing files for 2 cases (2 files each) and 5 short-read whole genome sequencing cases including the corresponding blood sample.
  • Dataset Released

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF50000054626 fastq.bz2 1.5 GB
EGAF50000054627 fastq.bz2 1.5 GB
EGAF50000054628 fastq.bz2 1.7 GB
EGAF50000054629 fastq.bz2 1.7 GB
EGAF50000054630 fastq.bz2 1.5 GB
EGAF50000054631 fastq.bz2 1.6 GB
EGAF50000054632 fastq.bz2 1.4 GB
EGAF50000054633 fastq.bz2 1.5 GB
EGAF50000054634 fastq.gz 874.5 MB
EGAF50000054635 fastq.gz 916.9 MB
EGAF50000054636 fastq.bz2 1.7 GB
EGAF50000054637 fastq.bz2 1.8 GB
EGAF50000054638 fastq.gz 1.5 GB
EGAF50000054639 fastq.gz 1.5 GB
EGAF50000054640 fastq.bz2 1.5 GB
EGAF50000054641 fastq.bz2 1.6 GB
EGAF50000054642 fastq.bz2 2.5 GB
EGAF50000054643 fastq.bz2 2.6 GB
EGAF50000054644 fastq.bz2 1.5 GB
EGAF50000054645 fastq.bz2 1.6 GB
EGAF50000054646 fastq.bz2 1.3 GB
EGAF50000054647 fastq.bz2 1.4 GB
EGAF50000054648 fastq.bz2 1.4 GB
EGAF50000054649 fastq.bz2 1.4 GB
EGAF50000054650 fastq.bz2 1.4 GB
EGAF50000054651 fastq.bz2 1.5 GB
EGAF50000054652 fastq.bz2 1.5 GB
EGAF50000054653 fastq.bz2 1.5 GB
EGAF50000054654 fastq.gz 4.5 GB
EGAF50000054655 fastq.gz 4.5 GB
EGAF50000054656 fastq.bz2 2.9 GB
EGAF50000054657 fastq.bz2 2.9 GB
EGAF50000054658 fastq.bz2 1.3 GB
EGAF50000054659 fastq.bz2 1.3 GB
EGAF50000054660 fastq.bz2 1.4 GB
EGAF50000054661 fastq.bz2 1.5 GB
EGAF50000054662 fastq.bz2 1.4 GB
EGAF50000054663 fastq.bz2 1.5 GB
EGAF50000054664 fastq.bz2 1.1 GB
EGAF50000054665 fastq.bz2 1.0 GB
EGAF50000099981 spring 40.4 GB
EGAF50000099982 spring 105.0 GB
EGAF50000099983 fastq.bz2 27.6 GB
EGAF50000099984 fastq.bz2 25.7 GB
EGAF50000099985 spring 38.1 GB
EGAF50000099986 spring 16.4 GB
EGAF50000099987 fastq.bz2 21.0 GB
EGAF50000099988 fastq.bz2 22.3 GB
EGAF50000099989 spring 41.2 GB
EGAF50000099990 spring 110.1 GB
EGAF50000099991 spring 29.0 GB
EGAF50000099992 spring 12.1 GB
EGAF50000099993 spring 97.8 GB
EGAF50000099994 spring 39.4 GB
54 Files (694.5 GB)